# EDGAR Filing Document

**Accession Number:** 0001411057
**File Stem:** 0000000000-26-003312
**Filing Date:** 2026-4
**Character Count:** 3030
**Document Hash:** 124bb0f7e9b8709f47d68e1273b236b4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003312.hdr.sgml**: 20260513

**ACCESSION NUMBER**: 0000000000-26-003312

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260401

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cannabis Bioscience International Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001411057
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 844901229
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 024-12731

**BUSINESS ADDRESS:**
- **STREET 1:** 6201 BONHOMME ROAD
- **STREET 2:** SUITE 435S
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77036
- **BUSINESS PHONE:** 214-733-0868

**MAIL ADDRESS:**
- **STREET 1:** 6201 BONHOMME ROAD
- **STREET 2:** SUITE 435S
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHINA INFRASTRUCTURE CONSTRUCTION Corp
- **DATE OF NAME CHANGE:** 20090916

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIDELITY AVIATION CORP
- **DATE OF NAME CHANGE:** 20070829
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001683168-26-002344

## Text-Extract

```

                                                             April 1, 2026

Dante Picazo
Principal Executive Officer
Cannabis Bioscience International Holdings, Inc.
6201 Bonhomme Road
Suite 435N
Houston, TX 77036

        Re: Cannabis Bioscience International Holdings, Inc.
            Offering Statement on Form 1-A
            Filed March 27, 2026
            File No. 024-12731
Dear Dante Picazo:

       This is to advise you that we do not intend to review your offering
statement.

        We will consider qualifying your offering statement at your request. If
a participant in
your offering is required to clear its compensation arrangements with FINRA,
please have
FINRA advise us that it has no objections to the compensation arrangements
prior to
qualification.

        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff. We also remind you that, following qualification of your
Form 1-A, Rule 257
of Regulation A requires you to file periodic and current reports, including a
Form 1-K which
will be due within 120 calendar days after the end of the fiscal year covered
by the report.

       Please contact Robert Augustin at 202-551-8483 with any questions.

                                                             Sincerely,

                                                             Division of
Corporation Finance
                                                             Office of
Industrial Applications and Services
cc:    Barry J. Miller

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._